Antihypertensives, statins, antiplatelets and diuretics, including the molecules behind most US fixed-dose combinations.
Amlodipine Besylate
Calcium channel blocker (dihydropyridine)
CAS 111470-99-6Atorvastatin Calcium
HMG-CoA reductase inhibitor (statin)
CAS 134523-03-8Rosuvastatin Calcium
HMG-CoA reductase inhibitor (statin)
CAS 147098-20-2Losartan Potassium
Angiotensin II receptor blocker
CAS 124750-99-8Valsartan
Angiotensin II receptor blocker
CAS 137862-53-4Telmisartan
Angiotensin II receptor blocker
CAS 144701-48-4Olmesartan Medoxomil
Angiotensin II receptor blocker (prodrug)
CAS 144689-63-4Metoprolol Succinate
Beta-1 selective adrenergic blocker
CAS 98418-47-4Carvedilol
Non-selective beta blocker with alpha-1 blocking activity
CAS 72956-09-3Clopidogrel Bisulfate
P2Y12 platelet inhibitor
CAS 120202-66-6Ezetimibe
Cholesterol absorption inhibitor
CAS 163222-33-1Hydrochlorothiazide
Thiazide diuretic
CAS 58-93-5Lisinopril
Angiotensin-converting enzyme (ACE) inhibitor
CAS 83915-83-7Spironolactone
Aldosterone antagonist
CAS 52-01-7Furosemide
Loop diuretic
CAS 54-31-9Fenofibrate
PPAR-alpha agonist (fibrate)
CAS 49562-28-9
The questions that come up most often when US quality teams qualify cardiovascular APIs.
Nitrosamines in the sartans
Losartan, valsartan and olmesartan are built around a tetrazole ring, the chemistry behind the 2018 NDMA recalls. Every sartan source should come with a nitrosamine risk assessment, confirmatory test data and an azido impurity statement.
Read the articleForm and particle size
Atorvastatin is sold as crystalline and as amorphous material, clopidogrel as two polymorphs, and ezetimibe, fenofibrate and spironolactone in micronized grades. The form you developed with has to be the form you buy.
One API, many product files
Amlodipine, hydrochlorothiazide and the sartans go into dozens of fixed-dose combinations. A change at the source can touch several of your applications at once, so change notification terms matter more here than anywhere.
How we handle it